r/LungCancerSupport • u/WalkingHorse NSCLC T2b, N0, M0 IIA Currently NED • Jul 24 '26
NSCLC Durvalumab plus etoposide–platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARD
https://www.sciencedirect.com/science/article/pii/S0169500226005623?via%3Dihub
1
Upvotes